Induction of meiotic recombination using a crispr system
AssigneesMeiogenix, Institut Curie, Centre National De La Recherche Scientifique, Sorbonne Universite
InventorsALAIN NICOLAS, ALEXANDRE SERERO, LUC MATHIS
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for inducing targeted meiotic recombination in a eukaryotic cell, wherein the method is designed to maintain efficient induction of meiotic recombination using a CRISPR system even after a large number of mitotic cell cycles by reducing of the activity of CRISPR nuclease outside of meiosis and/or using several guide gRNAs specific of different sites in a targeted chromosomal region thereby increasing the probability to retain at least one intact target site for gRNA available in each meiotic cell.
Claims24
1-31. (canceled)
A method for inducing targeted meiotic recombination in a cell, said method comprising:
- introducing into said cell:
- a) a CRISPR nuclease or a nucleic acid encoding said nuclease, and
- b) one or more guide RNAs or one or more nucleic acids encoding said guide RNAs, said guide RNAs comprising an RNA structure for binding to the CRISPR nuclease and a sequence complementary to a targeted chromosomal region and
- inducing said cell to enter meiotic prophase I,
- wherein the activity of the CRISPR nuclease is repressed outside of meiosis,
- wherein the CRISPR nuclease is not fused with a Spo11 protein, and
- wherein the cell is a yeast cell, a plant cell or a fungus cell.
A method for inducing targeted meiotic recombination in a cell, said method comprising:
- introducing into said cell:
- a) a CRISPR nuclease or a nucleic acid encoding said nuclease,
- b) a plurality of guide RNAs targeting the same chromosomal region or a plurality of nucleic acids encoding said guide RNAs, said guide RNAs comprising an RNA structure for binding to the CRISPR nuclease and a sequence complementary to a targeted chromosomal region;
- and
- c) a fusion protein comprising a Spo11 protein operably linked to a DNA binding domain, or a nucleic acid encoding said fusion protein, optionally under the control of a meiosis-specific promoter;
- and
- inducing said cell to enter meiotic prophase I,
- wherein the CRISPR nuclease is not fused with a Spo11 protein,
- optionally wherein the activity of the CRISPR nuclease is repressed outside of meiosis, and
- wherein the cell is a yeast cell, a plant cell or a fungus cell.
A method for generating variants of an organism, said method comprising:
- introducing into a cell of said organism:
- a) a CRISPR nuclease or a nucleic acid encoding said nuclease, and
- b) one or more guide RNAs or one or more nucleic acids encoding said guide RNAs, said guide RNAs comprising an RNA structure for binding to the CRISPR nuclease and a sequence complementary to a targeted chromosomal region and
- inducing said cell to enter meiotic prophase I,
- obtaining a cell or cells having the desired recombination(s) at the targeted chromosomal region(s);
- and
- generating a variant of the organism from said recombinant cell,
- wherein the activity of the CRISPR nuclease is repressed outside of meiosis,
- wherein the CRISPR nuclease is not fused with a Spo11 protein, and
- wherein the organism is a yeast, a plant or a fungus.
A method for generating variants of an organism, said method comprising:
- introducing into a cell of said organism:
- a) a CRISPR nuclease or a nucleic acid encoding said nuclease, and
- b) a plurality of guide RNAs targeting the same chromosomal region or a plurality of nucleic acids encoding said guide RNAs, said guide RNAs comprising an RNA structure for binding to the CRISPR nuclease and a sequence complementary to a targeted chromosomal region and
- inducing said cell to enter meiotic prophase I,
- obtaining a cell or cells having the desired recombination(s) at the targeted chromosomal region(s);
- and
- generating a variant of the organism from said recombinant cell,
- wherein the CRISPR nuclease is not fused with a Spo11 protein and wherein the activity of the CRISPR nuclease is repressed outside of meiosis, and
- wherein the organism is a yeast, a plant or a fungus.
A host cell comprising:
- a) a CRISPR nuclease or a nucleic acid encoding said nuclease, and
- b) one or more guide RNAs or one or more nucleic acids encoding said guide RNAs, said guide RNAs comprising an RNA structure for binding to the CRISPR nuclease and a sequence complementary to a targeted chromosomal region, and
- c) optionally a fusion protein comprising a Spo11 protein operably linked to a DNA binding domain, or a nucleic acid encoding said fusion protein,
- wherein the CRISPR nuclease is not fused with a Spo11 protein and
- wherein the activity of the CRISPR nuclease is repressed outside of meiosis by
- (i) placing the expression of said CRISPR nuclease and/or said guide RNAs under the control of a promoter inducible during the meiotic phase or a meiosis-specific promoter, and/or
- (ii) expressing an inhibitor of CRISPR endonuclease activity outside of meiosis, and/or
- (iii) using a system triggering the degradation of the CRISPR nuclease outside of meiosis, and/or
- (iv) using a CRISPR nuclease which is a variant of a wild-type CRISPR nuclease, said variant exhibiting a reduced endonuclease activity by comparison to said wild-type CRISPR nuclease;
- wherein the host cell is a yeast cell, a plant cell or a fungus cell.
Dependencies are inferred from the claim text.